Cyrus Karkaria, PhD
Advertisement
Dr. Cyrus Karkaria is President of Lupin's Biotechnology Businesses, leading the company's global biosimilars portfolio with over 30 years of biologic drug development experience at organizations including Biogen, CuraGen, and Celldex Therapeutics. He holds a post-doctorate from Harvard Medical School and a PhD. from the University of Maryland.
Articles by Cyrus Karkaria, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Retina Society 2026: MCO-010 optogenetic therapy maintains visual acuity gains through 4 years in advanced RP
2
Retina Society 2026: Medium-dose OCU410 gene therapy cuts geographic atrophy progression by up to 32% in phase 2 trial
3
Retina Society 2026: LUGANO secondary data show reduced treatment burden with vorolanib insert despite missed primary end point
4
Beyond the phenotype: Aqueous humor sampling moves retinoblastoma toward personalized therapy
5